Revisiting the prevalence of bipolar disorder: implications of a broader spectrum model

Bipolar affective disorder has traditionally been defined by episodic mania and depression, largely restricted to Bipolar I and II categories. However, growing evidence suggests this framework underrepresents the broader longitudinal spectrum and may misclassify a subset of cases as borderline personality disorder (BPD) or other comorbidities. A narrative review was conducted, integrating historical and conceptual analyses of diagnostic frameworks (DSM-III to DSM-5), epidemiological studies over four decades, and the author's extensive clinical experience with longitudinal follow-up of complex affective cases. Literature addressing comorbidity, diagnostic delays, and symptom overlap was critically examined within a comparative and hypothesis-oriented framework. Findings indicate that bipolar spectrum disorders (BPSD) are substantially underdiagnosed, with prevalence plausibly exceeding traditional categorical estimates when cumulative longitudinal spectrum phenomena are considered. The suggested prevalence range of 15-20% represents a theoretical upper-bound hypothesis derived from clinical extrapolation and longitudinal observation, rather than a definitive epidemiological estimate. Conditions commonly diagnosed as BPD, ADHD, or anxiety may, in a subset of cases, represent longitudinal affective presentations overlapping with the bipolar spectrum. Evidence supports a spectrum model encompassing multiple subtypes, such as bipolar with panic attacks, ADHD comorbidity, antidepressant-induced mania, and ultra-rapid cycling. The continued use of BPD as a diagnostic category is questioned due to poor construct validity and overlap with bipolarity. Reconceptualizing bipolar disorder as a spectrum within a cautiously framed longitudinal model is essential to improve diagnostic accuracy, guide treatment, and optimize long-term outcomes, while remaining subject to prospective empirical validation. This manuscript is explicitly framed as a narrative, hypothesis-generating review rather than a systematic review or meta-analysis; accordingly, prevalence estimates discussed herein should be regarded as exploratory and conceptual rather than definitive epidemiological claims.